Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from SARS-CoV-2 pan-variant inhibitory peptides deter S1-ACE2 interaction and neutralize delta and omicron pseudoviruses. Local targets link to admitted publications; unresolved targets remain external evidence.
Temporal signal and the phylodynamic threshold of SARS-CoV-2
10.1093/ve/veaa061 · 2020 · External reference
10.1126/science.abc8169
10.1126/science.abc8169 · External reference
10.1126/science.abb2507
10.1126/science.abb2507 · External reference
10.1038/ncomms15092
10.1038/ncomms15092 · External reference
The SARS-CoV-2 Spike Variant D614G Favors an Open Conformational State
2020 · External reference
The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity
2020 · External reference
10.1016/j.cell.2020.06.043
10.1016/j.cell.2020.06.043 · External reference
10.1038/s41579-021-00573-0
10.1038/s41579-021-00573-0 · External reference
10.1056/nejmsr2105280
10.1056/nejmsr2105280 · External reference
Neutralising antibodies drive Spike mediated SARS-CoV-2 evasion
2020 · External reference
10.1126/science.abh2644
10.1126/science.abh2644 · External reference
10.1016/j.ebiom.2020.102645
10.1016/j.ebiom.2020.102645 · External reference
10.1038/s41586-021-03398-2
10.1038/s41586-021-03398-2 · External reference
10.1056/nejmoa2102214
10.1056/nejmoa2102214 · External reference
Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies
10.3389/fimmu.2021.830527 · 2021 · External reference
10.1038/s41586-022-04474-x
10.1038/s41586-022-04474-x · External reference
10.1038/s41586-021-04385-3
10.1038/s41586-021-04385-3 · External reference
10.14348/molcells.2021.0026
10.14348/molcells.2021.0026 · External reference
10.1038/s41586-020-2180-5
10.1038/s41586-020-2180-5 · External reference
10.1038/s41586-020-2179-y
10.1038/s41586-020-2179-y · External reference
10.1021/cc0500607
10.1021/cc0500607 · External reference
10.1016/j.virol.2006.01.029
10.1016/j.virol.2006.01.029 · External reference
Investigation of ACE2 N-terminal fragments binding to SARS-CoV-2 Spike RBD
2020 · External reference
10.1016/j.csbj.2020.11.002 · Admitted local publication
10.1038/s41423-020-0458-z
10.1038/s41423-020-0458-z · External reference
10.1101/2020.03.16.994236
10.1101/2020.03.16.994236 · External reference
10.1016/j.jmb.2007.05.022
10.1016/j.jmb.2007.05.022 · External reference
DrugScorePPI webserver: fast and accurate in silico alanine scanning for scoring protein-protein interactions
2010 · External reference
10.1016/0263-7855(96)00018-5
10.1016/0263-7855(96)00018-5 · External reference
In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response
10.1038/srep13446 · 2015 · External reference
10.1016/j.jmb.2019.02.028
10.1016/j.jmb.2019.02.028 · External reference
10.1002/anie.201502763
10.1002/anie.201502763 · External reference
10.1016/j.drudis.2013.05.011
10.1016/j.drudis.2013.05.011 · External reference
10.1016/j.drudis.2014.10.003
10.1016/j.drudis.2014.10.003 · External reference
10.1021/acs.jmedchem.9b00061
10.1021/acs.jmedchem.9b00061 · External reference
10.1002/prot.22711
10.1002/prot.22711 · External reference
10.1093/bioinformatics/btt055
10.1093/bioinformatics/btt055 · External reference
Optimizing working parameters of the smooth particle mesh Ewald algorithm in terms of accuracy and efficiency
10.1063/1.3446812 · 2010 · External reference
Open source drug discovery C, Lynn A. g_mmpbsa–a GROMACS tool for high-throughput MM-PBSA calculations
10.1021/ci500020m · 2014 · External reference
10.1002/jcc.20084
10.1002/jcc.20084 · External reference
10.1039/c3mb25484d
10.1039/c3mb25484d · External reference
Insights into the species-specific TLR4 signaling mechanism in response to Rhodobacter sphaeroides lipid A detection
10.1038/srep07657 · 2015 · External reference
10.1021/ci049885e
10.1021/ci049885e · External reference
10.1016/j.softx.2015.06.001 · Admitted local publication
10.3390/v12050513
10.3390/v12050513 · External reference
Discovery of small anti-ACE2 peptides to inhibit SARS-CoV-2 infectivity
2021 · External reference
10.1021/acscentsci.0c01309
10.1021/acscentsci.0c01309 · External reference
10.1021/acscentsci.0c01708
10.1021/acscentsci.0c01708 · External reference
10.1038/s42003-021-01736-8
10.1038/s42003-021-01736-8 · External reference
Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein
2021 · External reference
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
2020 · External reference
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2
2020 · External reference
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
2021 · External reference
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation and antigenicity
2021 · External reference
Surface plasmon resonance (SPR) analysis of binding interactions of proteins in inner-ear sensory epithelia
10.1007/978-1-59745-523-7_20 · 2009 · External reference
Comparison of biosensor platforms in the evaluation of high affinity antibody-antigen binding kinetics
10.1016/j.ab.2016.06.024 · 2016 · External reference
Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screening
10.1038/s41598-021-99401-x · 2021 · External reference
10.1080/22221751.2021.1978823
10.1080/22221751.2021.1978823 · External reference
10.1084/jem.20201181
10.1084/jem.20201181 · External reference
A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques
2021 · External reference
10.1186/1752-0509-8-44
10.1186/1752-0509-8-44 · External reference
10.1038/s41586-020-2548-6
10.1038/s41586-020-2548-6 · External reference
10.1038/s41586-020-2380-z
10.1038/s41586-020-2380-z · External reference
10.1016/j.cell.2020.05.025
10.1016/j.cell.2020.05.025 · External reference
10.1016/s0145-305x(02)00039-3
10.1016/s0145-305x(02)00039-3 · External reference
10.1038/msb.2011.75
10.1038/msb.2011.75 · External reference
Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation
2020 · External reference
10.1016/j.cell.2021.04.032
10.1016/j.cell.2021.04.032 · External reference
10.1016/j.chom.2020.06.010
10.1016/j.chom.2020.06.010 · External reference
10.1021/acs.jmedchem.1c00655
10.1021/acs.jmedchem.1c00655 · External reference
10.1073/pnas.2003138117
10.1073/pnas.2003138117 · External reference
10.1101/2020.08.06.238915
10.1101/2020.08.06.238915 · External reference
10.1016/j.celrep.2020.108528
10.1016/j.celrep.2020.108528 · External reference
10.1016/j.cell.2020.04.004
10.1016/j.cell.2020.04.004 · External reference
Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine
2020 · External reference
10.1056/nejmoa2027906
10.1056/nejmoa2027906 · External reference
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M(pro) and cathepsin L
10.1126/sciadv.abe0751 · 2020 · External reference
Structure-based drug designing and immunoinformatics approach for SARS-CoV-2
10.1126/sciadv.abb8097 · 2020 · External reference
10.1038/s41422-020-0305-x
10.1038/s41422-020-0305-x · External reference
10.1038/nrd892
10.1038/nrd892 · External reference
10.1016/j.addr.2020.11.007
10.1016/j.addr.2020.11.007 · External reference
10.1038/s41467-021-21825-w
10.1038/s41467-021-21825-w · External reference
Cyclic parathyroid hormone related protein antagonists: lysine 13 to aspartic acid 17 [i to (i + 4)] side chain to side chain lactamization
10.1021/bi00238a022 · 1991 · External reference
10.1073/pnas.1002498107
10.1073/pnas.1002498107 · External reference
Stapled peptides based on human angiotensin-converting enzyme 2 (ACE2) potently inhibit SARS-CoV-2 infection in vitro
10.1128/mbio.02451-20 · 2020 · External reference
GLP-1 analogs containing disulfide bond exhibited prolonged half-life in vivo than GLP-1
10.1016/j.peptides.2011.04.001 · 2011 · External reference
10.1021/acs.biomac.8b01209
10.1021/acs.biomac.8b01209 · External reference
